Nduka M Amankulor1, Ran Xu2, J Bryan Iorgulescu3, Talia Chapman4, Anne S Reiner5, Elyn Riedel5, Eric Lis6, Yoshiya Yamada7, Mark Bilsky3, Ilya Laufer8. 1. Department of Neurological Surgery, University of Pittsburgh School of Medicine, 200 Lothrop St, Pittsburgh, PA 15213, USA. 2. Department of Neurological Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA; Department of Medical Biophysics, Institute of Physiology and Pathophysiology, Heidelberg University, Grabengasse 1, 69117 Heidelberg, Germany. 3. Department of Neurological Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA; Department of Neurological Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 1305 York Ave., New York, NY 10065, USA. 4. Columbia College of Physicians and Surgeons, Columbia University, 630 W 168th St, New York, NY 10032, USA. 5. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA. 6. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA. 7. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA. 8. Department of Neurological Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA; Department of Neurological Surgery, Weill Cornell Medical College, New York-Presbyterian Hospital, 1305 York Ave., New York, NY 10065, USA. Electronic address: lauferi@mskcc.org.
Abstract
BACKGROUND CONTEXT: Spine metastases occur frequently in patients with cancer. A variety of surgical approaches, including anterior transcavitary, lateral extracavitary, posterolateral, and/or combined techniques are used for spinal cord decompression and restoration of spinal stability. The incidence of symptomatic hardware failure is unknown for the majority of these approaches. PURPOSE: The purpose of this study was to determine the incidence of symptomatic hardware failure and the associated risk factors in patients with metastatic epidural spinal cord compression (MESCC). STUDY DESIGN/ SETTING: This was a retrospective study. PATIENT SAMPLE: The current series analyzes a cohort of 318 patients who underwent separation surgery, which involves single-stage posterolateral decompression and posterior segmental instrumentation for MESCC. OUTCOME MEASURES: The event of interest was hardware failure; the competing event was death resulting from any cause. All patients were monitored for survival analysis. A competing risk analysis was conducted to examine univariately a number of potential risk factors associated with hardware failure, including junctional level, gender, construct length, and the presence or absence of prior chest wall resection. METHODS: A retrospective analysis and chart review were performed for 318 consecutive patients who underwent posterolateral decompression and posterior screw-rod fixation without supplemental anterior fixation from March 2004 to June 2011 at our institution. The median follow-up time for survivors without hardware failure was 399 days (range, 9-2,828), with a mean operative time of 3 hours. A total of 78% of patients died during the 7-year study period. RESULTS: Of the 318 patients, nine (2.8%) exhibited signs and symptoms of hardware failure and required revision of the instrumentation. Patients with chest wall resection and those with initial construct length greater than six contiguous spinal levels exhibited a statistically significantly higher risk of symptomatic hardware failure than their counterparts. We observed a trend toward an increased risk of failure in women compared with men (p=.09). CONCLUSIONS: The incidence of hardware failure is low in patients with MESCC who undergo posterolateral decompression and posterior screw-rod instrumentation. Moreover, the short operative time and low morbidity profile associated with this approach make it a reliable and acceptable method for the surgical treatment of MESCC. Patients with constructs spanning six or more levels or those with prior chest wall resection are at higher risk for instrumentation failure.
BACKGROUND CONTEXT: Spine metastases occur frequently in patients with cancer. A variety of surgical approaches, including anterior transcavitary, lateral extracavitary, posterolateral, and/or combined techniques are used for spinal cord decompression and restoration of spinal stability. The incidence of symptomatic hardware failure is unknown for the majority of these approaches. PURPOSE: The purpose of this study was to determine the incidence of symptomatic hardware failure and the associated risk factors in patients with metastatic epidural spinal cord compression (MESCC). STUDY DESIGN/ SETTING: This was a retrospective study. PATIENT SAMPLE: The current series analyzes a cohort of 318 patients who underwent separation surgery, which involves single-stage posterolateral decompression and posterior segmental instrumentation for MESCC. OUTCOME MEASURES: The event of interest was hardware failure; the competing event was death resulting from any cause. All patients were monitored for survival analysis. A competing risk analysis was conducted to examine univariately a number of potential risk factors associated with hardware failure, including junctional level, gender, construct length, and the presence or absence of prior chest wall resection. METHODS: A retrospective analysis and chart review were performed for 318 consecutive patients who underwent posterolateral decompression and posterior screw-rod fixation without supplemental anterior fixation from March 2004 to June 2011 at our institution. The median follow-up time for survivors without hardware failure was 399 days (range, 9-2,828), with a mean operative time of 3 hours. A total of 78% of patients died during the 7-year study period. RESULTS: Of the 318 patients, nine (2.8%) exhibited signs and symptoms of hardware failure and required revision of the instrumentation. Patients with chest wall resection and those with initial construct length greater than six contiguous spinal levels exhibited a statistically significantly higher risk of symptomatic hardware failure than their counterparts. We observed a trend toward an increased risk of failure in women compared with men (p=.09). CONCLUSIONS: The incidence of hardware failure is low in patients with MESCC who undergo posterolateral decompression and posterior screw-rod instrumentation. Moreover, the short operative time and low morbidity profile associated with this approach make it a reliable and acceptable method for the surgical treatment of MESCC. Patients with constructs spanning six or more levels or those with prior chest wall resection are at higher risk for instrumentation failure.
Authors: Ori Barzilai; Lily McLaughlin; Eric Lis; Anne S Reiner; Mark H Bilsky; Ilya Laufer Journal: Oper Neurosurg (Hagerstown) Date: 2019-05-01 Impact factor: 2.703
Authors: Zain A Husain; Arjun Sahgal; Eric L Chang; Pejman Jabehdar Maralani; Charlotte D Kubicky; Kristin J Redmond; Charles Fisher; Ilya Laufer; Simon S Lo Journal: CNS Oncol Date: 2017-07-18
Authors: Ori Barzilai; Ilya Laufer; Adam Robin; Ran Xu; Yoshiya Yamada; Mark H Bilsky Journal: Oper Neurosurg (Hagerstown) Date: 2019-03-01 Impact factor: 2.703
Authors: Marc Dreimann; Michael Hoffmann; Lennart Viezens; Lukas Weiser; Patrick Czorlich; Sven Oliver Eicker Journal: Eur Spine J Date: 2016-10-11 Impact factor: 3.134
Authors: Oluwaseun O Akinduro; Gaetano De Biase; Anshit Goyal; Jenna H Meyer; Sukhwinder J S Sandhu; Roman O Kowalchuk; Daniel M Trifiletti; Jason Sheehan; Kenneth W Merrell; Sujay A Vora; Daniel F Broderick; Michelle J Clarke; Mohamad Bydon; Jamal McClendon; Maziyar A Kalani; Alfredo Quiñones-Hinojosa; Kingsley Abode-Iyamah Journal: J Neurooncol Date: 2022-01-07 Impact factor: 4.130
Authors: Ori Barzilai; Lily McLaughlin; Mary-Kate Amato; Anne S Reiner; Shahiba Q Ogilvie; Eric Lis; Yoshiya Yamada; Mark H Bilsky; Ilya Laufer Journal: World Neurosurg Date: 2018-09-04 Impact factor: 2.104
Authors: Ori Barzilai; Mary-Kate Amato; Lily McLaughlin; Anne S Reiner; Shahiba Q Ogilvie; Eric Lis; Yoshiya Yamada; Mark H Bilsky; Ilya Laufer Journal: Neurooncol Pract Date: 2017-07-22